Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Gilles Montalescot Jean-Philippe Collet Jean-Pierre Cazenave |
| Publication date | December 1, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |